CarrerasLeaders Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers
- Coordinator
- Fundacio Institut De Recerca Contra La Leucemia Josep Carreras, Spain
- Runs
- 1 January 2023 to 31 December 2028
- Status
- Running
- EU funding
- €2.3m
- Total cost
- —
- Partners
- 46 organisations in 13 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101081347
What the project is doing
In the project's own words, from its summary on CORDIS.
CarrerasLeaders is a new innovative and international postdoctoral programme, designed by Josep Carreras Leukaemia Research Institute (IJC), an independent, non-profit biomedical research institute that is part of the Government of Catalonia network of Research Centres (CERCA). IJC is the first European institute exclusively devoted to leukaemia and other malignant blood diseases. The aim of the programme is to fund 16 excellent postdoctoral researchers for a period of 36 months.
The selection of the fellows is merit-based, founded on peer review in an open and transparent selection procedure. Carrerasleaders is addressed to boost career perspective of researchers from a three-dimensional perspective: leadership, independence, and consolidation. This is a world-wide unique postdoctoral program that covers the entire spectrum of research and innovation in blood cancers and goes from understanding disease biology to the implementation of products and processes in the market and into the clinical practice through the development of a global translational approach.
Applicants will have complete freedom of research choice within the scope of blood cancers and will be offer highly attractive working conditions and a healthy, inspiring and creative working environment. CarrerasLeaders is designed based on the following objectives: 1. Training the next generation of scientist leaders to advance on the cure of blood cancers, multiplying each one’s skills sets and networks via targeted Career Development Plans and mentoring.2.Improve the quality of blood cancers postdoctoral research training, more targeted addressed to the researchers and societal needs. 3.Enhanced cooperation and transfer knowledge between sectors and disciplines.4.Enable outstanding junior researchers to develop their research careers to an advanced and more independent level in a leading institution such as IJC. 5.Increase the competitiveness of the IJC blood cancers community
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fundacio Institut De Recerca Contra La Leucemia Josep Carreras | Badalona | Spain | Coordinator |
| University of Sharjah | Sharjah | AE | Associatedpartner |
| Universite Libre De Bruxelles | Bruxelles | Belgium | Associatedpartner |
| Ecole Polytechnique Federale De Lausanne | Lausanne | Switzerland | Associatedpartner |
| Fondazione per L'istituto Oncologico Di Ricerca (ior) | Bellinzona | Switzerland | Associatedpartner |
| Ibm Research GmbH | Rueschlikon | Switzerland | Associatedpartner |
| Ustav Molekularni Genetiky Av Cr V.v.i. | Praha 4 | Czechia | Associatedpartner |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Associatedpartner |
| Deutsches Krebsforschungszentrum Heidelberg | Heidelberg | Germany | Associatedpartner |
| Genome Identification Diagnostics GmbH | Strassberg | Germany | Associatedpartner |
| Leadership Sculptor GmbH | Baden-Baden | Germany | Associatedpartner |
| Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV | Munchen | Germany | Associatedpartner |
| Medizinische Hochschule Hannover | Hannover | Germany | Associatedpartner |
| Miltenyi Biotec BV & Co Kg | Bergisch Gladbach | Germany | Associatedpartner |
| Mll Munchner Leukamielabor GmbH | Munchen | Germany | Associatedpartner |
| Agencia De Gestio D'ajuts Universitaris I De Recerca | Barcelona | Spain | Associatedpartner |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Associatedpartner |
| Anaxomics Biotech SL | Barcelona | Spain | Associatedpartner |
| Applied Nanoparticles SL | Barcelona | Spain | Associatedpartner |
| Applied Research Using Omic Sciences SL | Barcelona | Spain | Associatedpartner |
| Asociación Española Contra el Cáncer | Madrid | Spain | Associatedpartner |
| Fundacio Institucio Dels Centres De Recerca De Catalunya | Barcelona | Spain | Associatedpartner |
| Fundacio Institut De Recerca Biomedica (irb Barcelona) | Barcelona | Spain | Associatedpartner |
| Fundacion Cientifica De La Asociación Espanola Contra El Cancer | Madrid | Spain | Associatedpartner |
| Fundació Internacional Josep Carreras | Barcelona | Spain | Associatedpartner |
| Gavin Lucas | Barcelona | Spain | Associatedpartner |
| Mesoestetic Pharma Group S.l. | Viladecans | Spain | Associatedpartner |
| Onechain Immunotherapeutics S.l. | Barcelona | Spain | Associatedpartner |
| Quimatryx SL | San Sebastian | Spain | Associatedpartner |
| Scienseed SL | Madrid | Spain | Associatedpartner |
| Universidad Pompeu Fabra | Barcelona | Spain | Associatedpartner |
| Zeclinics SL | Sant Feliu De Llobregat | Spain | Associatedpartner |
| Semmelweis Egyetem | Budapest | Hungary | Associatedpartner |
| Humanitas Mirasole SpA | Rozzano (Mi) | Italy | Associatedpartner |
| Immagina Biotechnology SRL | Trento | Italy | Associatedpartner |
| Kither Biotech SRL | Torino | Italy | Associatedpartner |
| European Hematology Association | Den Haag | Netherlands | Associatedpartner |
| GenomeScan B.V. | Leiden | Netherlands | Associatedpartner |
| Universitetet I Oslo | Oslo | Norway | Associatedpartner |
| Fundacao Gimm - Gulbenkian Institute for Molecular Medicine | Lisboa | Portugal | Associatedpartner |
| Genome Research Limited Lbg | Saffron Walden | United Kingdom | Associatedpartner |
| Novogene UK Company Limited | London | United Kingdom | Associatedpartner |
| University of Newcastle Upon Tyne | Newcastle Upon Tyne | United Kingdom | Associatedpartner |
| International Society for Experimental Hematology | Chicago | United States | Associatedpartner |
| New York University | New York | United States | Associatedpartner |
| Trustees of Columbia University in the City of New York | New York | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI